MENU
BCRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioCryst Pharmaceuticals (BCRX) Earnings Date & Reports
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
BCRX is expected to report earnings to fall 66.67% to 10 cents per share on November 02
Q3'26
Est.
$0.10
Q2'26
Beat
by $0.14
Q1'26
Missed
by $3.03
Q4'25
Beat
by $1.08
Q3'25
Beat
by $0.11
The last earnings report on August 05 showed earnings per share of 30 cents, beating the estimate of 15 cents. With 1.73M shares outstanding, the current market capitalization sits at 1.98B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of small molecule pharmaceuticals
Industry PharmaceuticalsGeneric
Industry
Biotechnology
Address
4505 Emperor Boulevard
Phone
+1 919 859-1302
Employees
435
Web
https://www.biocryst.com